Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience. Cacciapuoti S, Potestio L, Gallo L, Musumeci ML, et al. Int J Dermatol 2025;64:319-324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cacciapuoti S, Potestio L, Gallo L, Musumeci ML, et al. Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience. Int J Dermatol 2025;64:319-324.
PMID: 38997809